199800.KQ
툴젠
KOE · Healthcare · Medical - Specialties · KR
KRW 30,950.00
+3.86%Year over year
Reported trailing growth
- Revenue
- +116.7%
- EBITDA
- —
- EBIT
- -10.4%
- EPS
- —
- Free cash flow
- -38.9%
- Operating cash flow
- -29.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +20.7%
- EBITDA
- —
- EBIT
- -8.8%
- Net income
- —
- EPS
- —
- Free cash flow
- -21.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026